RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sona Nanotech Stock

Sona Nanotech Stocks 2024

Sona Nanotech Stocks

85.75 M

Ticker

SONA.CN

ISIN

CA83541C1059

WKN

A2N64Z

In 2024, Sona Nanotech had 85.75 M outstanding stocks, a 0% change from the 85.75 M stocks in the previous year.

The Sona Nanotech Stocks history

YEARNUMBER OF STOCKS (undefined CAD)
2025e85.75
2024e85.75
202385.75
202268.41
202164.05
202060.18
201954.74
201827.5
201717.67

Sona Nanotech shares outstanding

The number of shares was Sona Nanotech in 2023 — This indicates how many shares 85.752 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sona Nanotech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sona Nanotech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sona Nanotech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sona Nanotech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sona Nanotech Aktienanalyse

What does Sona Nanotech do?

Sona Nanotech Inc. is an innovative company specializing in the development and commercialization of highly specific, ultrasensitive diagnostic tests for the medical sector. The Canadian company, headquartered in Halifax, was founded in 2012 and has since become a global leader in nanoparticle diagnostics. The idea for the establishment of Sona Nanotech was based on the research of founders Dr. Gerrard Marangoni and Dr. Kulbir Singh. The two scientists worked at Dalhousie University in Nova Scotia and developed a novel technology to detect specific target molecules in blood or urine. This technology is based on the use of gold nanoparticles coated with specific antibodies or aptamers. The purpose of these nanoparticles is to detect specific molecules in blood or urine and confirm their presence or absence as a result of analysis. Sona Nanotech's business model involves the development, manufacturing, and distribution of these nanoparticles. The company offers a wide range of diagnostic test services, with a focus on developing specific tests for various diseases. To this end, Sona Nanotech has established its own research and development department, which works closely with clinics, hospitals, and government agencies to better understand and respond to the needs of the medical community. Sona Nanotech is divided into several business areas. The main area is the sale of diagnostic tests, such as Covid-19 rapid tests, for the medical sector. These tests have been developed to detect the presence of viral particles in blood or urine. Sona Nanotech also offers specific tests for other diseases such as cancer or HIV. In addition to these standard tests, the company also offers customized solutions for the medical sector. Another business field of Sona Nanotech is research and development in the field of nanoparticle diagnostics. The company heavily invests in the advancement of its technology and continuously works on new applications for its nanoparticles. This also includes collaboration with scientific institutions and partners in the field of nanotechnology. In recent years, Sona Nanotech has significantly expanded its presence in the global market. The company works with partners around the world and operates its own branches in the United States and Europe. The product range has also been expanded: In addition to diagnostic tests, the company also offers various products based on its nanoparticle technology. This includes special color markers for the detection of viruses and bacteria, as well as products for environmental monitoring and food safety. Sona Nanotech has quickly become one of the leading companies in the field of nanoparticle diagnostics. The company is proud to actively contribute to improving medical care and saving lives. By continuing research and development in the field of nanoparticles, the company hopes to develop new and innovative solutions for the medical sector in the future. Sona Nanotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Sona Nanotech's Shares Outstanding

Sona Nanotech's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Sona Nanotech’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Sona Nanotech’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Sona Nanotech’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Sona Nanotech stock

How many stocks are there of Sona Nanotech?

The current number of stocks of Sona Nanotech is 85.75 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Sona Nanotech are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Sona Nanotech evolved in recent years?

The number of shares of Sona Nanotech has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Sona Nanotech as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Sona Nanotech?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Sona Nanotech pay?

Over the past 12 months, Sona Nanotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sona Nanotech is expected to pay a dividend of 0 CAD.

What is the dividend yield of Sona Nanotech?

The current dividend yield of Sona Nanotech is .

When does Sona Nanotech pay dividends?

Sona Nanotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sona Nanotech?

Sona Nanotech paid dividends every year for the past 0 years.

What is the dividend of Sona Nanotech?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sona Nanotech located?

Sona Nanotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sona Nanotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sona Nanotech from 11/9/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did Sona Nanotech pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of Sona Nanotech in the year 2023?

In the year 2023, Sona Nanotech distributed 0 CAD as dividends.

In which currency does Sona Nanotech pay out the dividend?

The dividends of Sona Nanotech are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sona Nanotech

Our stock analysis for Sona Nanotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sona Nanotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.